Trials / Completed
CompletedNCT06278480
Clinical Trial to Evaluate the Regeneration of Articular Cartilage Through Arthroscopy After MegaCarti® Application
Clinical Trial to Evaluate the Regeneration of Articular Cartilage Through Arthroscopy After MegaCarti® Application : Multicenter, Comparative, Evaluator-blinded, Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- L&C Bio · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The MegaCarti® is the decellularized allogeneic cartilage and acts as a cover after bone marrow stimulation to prevent the loss of blood clots and induces cartilage regeneration by assisting in the location of stem cells derived from bone marrow. During the 48-week confirmatory clinical trial of MegaCarti®, patients who simultaneously underwent high tibial osteotomy(HTO) were treated with a group in which MegaCarti® was implanted after microfracture and a group in which microfracture alone was performed. Cartilage regeneration is evaluated in patients with arthroscopy data at the time of fixation removal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MegaCarti® | Medical devices containing allogeneic cartilage |
| PROCEDURE | microfracture | microfracture |
Timeline
- Start date
- 2023-06-23
- Primary completion
- 2024-03-29
- Completion
- 2024-03-29
- First posted
- 2024-02-26
- Last updated
- 2024-10-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06278480. Inclusion in this directory is not an endorsement.